Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 6 studies | 24% ± 8% | |
| CD4-positive, alpha-beta T cell | 5 studies | 16% ± 1% | |
| epithelial cell | 5 studies | 27% ± 10% | |
| ciliated cell | 5 studies | 23% ± 9% | |
| dendritic cell | 4 studies | 25% ± 5% | |
| regulatory T cell | 4 studies | 18% ± 2% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 16% ± 1% | |
| neuron | 3 studies | 30% ± 7% | |
| retinal ganglion cell | 3 studies | 68% ± 22% | |
| natural killer cell | 3 studies | 19% ± 4% | |
| abnormal cell | 3 studies | 17% ± 1% | |
| goblet cell | 3 studies | 19% ± 2% | |
| oligodendrocyte | 3 studies | 23% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 100% | 5382.27 | 180 / 180 | 100% | 103.18 | 430 / 430 |
| pancreas | 100% | 4677.99 | 328 / 328 | 100% | 86.72 | 178 / 178 |
| uterus | 100% | 5905.52 | 170 / 170 | 100% | 89.39 | 459 / 459 |
| brain | 100% | 6069.74 | 2640 / 2642 | 100% | 101.59 | 705 / 705 |
| lung | 100% | 4531.88 | 578 / 578 | 100% | 85.41 | 1154 / 1155 |
| thymus | 100% | 5904.13 | 653 / 653 | 100% | 123.21 | 604 / 605 |
| prostate | 100% | 5356.68 | 245 / 245 | 100% | 107.27 | 501 / 502 |
| liver | 100% | 3167.10 | 226 / 226 | 100% | 60.44 | 405 / 406 |
| kidney | 100% | 4739.34 | 89 / 89 | 100% | 91.96 | 898 / 901 |
| stomach | 100% | 4631.25 | 359 / 359 | 100% | 76.30 | 285 / 286 |
| intestine | 100% | 5489.79 | 966 / 966 | 100% | 92.36 | 525 / 527 |
| breast | 100% | 5200.43 | 459 / 459 | 100% | 81.18 | 1113 / 1118 |
| esophagus | 100% | 4879.14 | 1445 / 1445 | 99% | 57.68 | 182 / 183 |
| bladder | 100% | 5063.43 | 21 / 21 | 99% | 86.93 | 501 / 504 |
| skin | 100% | 4151.97 | 1809 / 1809 | 99% | 71.52 | 469 / 472 |
| adrenal gland | 100% | 7194.33 | 258 / 258 | 99% | 104.60 | 228 / 230 |
| adipose | 100% | 4405.96 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 5398.50 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 79.71 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 73.38 | 29 / 29 |
| muscle | 100% | 4530.27 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 6810.79 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 97.76 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 55.81 | 1 / 1 |
| heart | 100% | 4116.87 | 860 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 87% | 2374.14 | 805 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0005813 | Cellular component | centrosome |
| GO_0005869 | Cellular component | dynactin complex |
| GO_0034774 | Cellular component | secretory granule lumen |
| GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005829 | Cellular component | cytosol |
| GO_0015630 | Cellular component | microtubule cytoskeleton |
| GO_0005576 | Cellular component | extracellular region |
| GO_0016020 | Cellular component | membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005515 | Molecular function | protein binding |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | ACTR1B |
| Protein name | Beta-centractin (Actin-related protein 1B) (ARP1B) |
| Synonyms | CTRN2 |
| Description | FUNCTION: Component of a multi-subunit complex involved in microtubule based vesicle motility. It is associated with the centrosome. |
| Accessions | P42025 ENST00000289228.7 ENST00000708081.1 |